Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Explained: How Long Is Ophthalmology Residency?
Embarking on a career in ophthalmology involves a meticulous journey of education and training, with the residency period being a critical phase in shaping a future ophthalmologist’s expertise. The duration of an ophthalmology residency is a key consideration for aspiring…
FDA Approval and Funding for ONS-5010
In a significant stride towards advancing its clinical development program for ONS-5010, Outlook Therapeutics has received written agreement from the FDA under a special protocol assessment (SPA) for the NORSE EIGHT clinical trial protocol. This trial aims to evaluate the…
FTC Clears Amgen’s Acquisition of Horizon Therapeutics
Amgen is set to proceed with its acquisition of Horizon Therapeutics after reaching an agreement with the Federal Trade Commission (FTC). This agreement clears the way for Amgen to complete its acquisition of Horizon Therapeutics, a deal valued at $27.8…
Allotex Receives Funding for Allogeneic Presbyopia Inlays
Allotex and SpA have announced the successful completion of the first close of their $30 million Series B financing. The funds raised will be utilized to further develop their technology aimed at treating refractive errors. The decision to invest in…
DigitalOptometrics Launches Real-Time Translation Service
DigitalOptometrics has unveiled a revolutionary solution to enhance patient care with the launch of “DOT” (DigitalOptometrics Translate), a real-time translation service designed to break down language barriers in the optometric industry. The innovative “DOT” technology facilitates seamless communication between eye…
New Study Reveals Insights into Glaucoma in Africans
A team of investigators unveiled previously unknown inherited genetic variants associated with primary open-angle glaucoma (POAG), the most prevalent form of the disease. The study, based on the analysis of 11,275 individuals of African descent, sheds light on the genetic…
iuvo BioScience Completes Acquisition of Promedica
iuvo BioScience, a prominent Partner Research Organization (PROTM), announced its successful acquisition of Promedica International, a California Corporation, specializing in ophthalmology-focused clinical Contract Research Organization (CRO) services. The strategic move is poised to create a global leader in delivering comprehensive…
OBN Spotlight TV: Interview with Filomena Ribeiro, MD
Ophthalmology Breaking News (OBN) is thrilled to present the first-ever interview with Dr. Filomena Ribeiro as the newly appointed President of the European Society of Cataract and Refractive Surgeons (ESCRS), effective January 1, 2024, succeeding Prof. Oliver Findl. Delve into…
Gentex Acquires eSight to Develop Electronic Eyewear
Gentex, a global leader in electro-optical products, announced a significant move towards enhancing accessibility with the acquisition of eSight, a leading company in vision enhancement technologies. The strategic acquisition is aimed at developing and manufacturing next-generation mobile electronic eyewear, specifically…
Aviceda Launches Phase 2 Clinical Trial for AVD-104
Aviceda Therapeutics announced a significant milestone in the development of its lead ophthalmic candidate, AVD-104, with the enrollment of the first patient in the GLYCO phase 2 US clinical trial. The trial aims to evaluate the efficacy and safety of…